Silo Pharma (SILO) Prepaid Assets (2017 - 2026)
Silo Pharma (SILO) posted Prepaid Assets of $529386.0 for Q1 2026, up 153.83% sequentially from $208559.0 in Q4 2025, and up 153.83% YoY from $208559.0 in Q1 2025.
Silo Pharma (SILO) Prepaid Assets (2017 - 2026) Analysis & Trends
Silo Pharma has reported Prepaid Assets for 10 years, with the latest figure at $529386.0 in Q1 2026.
- Quarterly Prepaid Assets rose 153.83% year-over-year to $529386.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $529386.0 (up 153.83% YoY) and the FY2025 annual result came in at $208559.0, up 573.71% from the prior year.
- Prepaid Assets advanced to $529386.0 in Q1 2026 per SILO's latest filing, from $208559.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $581373.0 in Q3 2022 and troughed at $15970.0 in Q4 2023.
- A 5-year average of $194584.9 and a median of $181710.0 in 2022 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets tumbled 91.21% in 2023, then jumped 573.71% in 2025.
- Over 5 years, Prepaid Assets stood at $181710.0 in 2022, then sank by 91.21% to $15970.0 in 2023, then jumped by 93.84% to $30957.0 in 2024, then surged by 573.71% to $208559.0 in 2025, then jumped by 153.83% to $529386.0 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $529386.0, $208559.0, and $225880.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Silo Pharma | 2.92 Mn | 2.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 280,870.00 |
| Mar 31, 2026 | 529,386.00 |
| Dec 31, 2025 | 208,559.00 |
| Sep 30, 2025 | 225,880.00 |
| Jun 30, 2025 | 113,062.00 |
| Mar 31, 2025 | 208,559.00 |
| Dec 31, 2024 | 30,957.00 |
| Sep 30, 2024 | 246,454.00 |
| Jun 30, 2024 | 120,288.00 |
| Mar 31, 2024 | 133,764.00 |
| Dec 31, 2023 | 15,970.00 |
| Sep 30, 2023 | 79,909.00 |
| Jun 30, 2023 | 121,334.00 |
| Mar 31, 2023 | 204,348.00 |
| Dec 31, 2022 | 181,710.00 |
| Sep 30, 2022 | 581,373.00 |
| Jun 30, 2022 | 99,939.00 |
| Mar 31, 2022 | 206,451.00 |
| Dec 31, 2021 | 100,570.00 |
| Sep 30, 2021 | 220,590.00 |